Anti-ADHD

GeneTrait Anti-ADHD Panel

GeneTrait's Anti-ADHD panel evaluates genetic markers responsible for metabolism of many common medications related to attention-deficit/hyperactivity disorder, plus elevated risk of hyperhomocysteinemia.

NUMBER OF INDIVIDUAL GENES TESTED:

• 6

MEDICATION CATEGORIES:

• Anti-ADHD

RISK FACTORS EVALUATED:

• Hyperhomocysteinemia